Clinical efficacy of infliximab plus methotrexate in DMARD-naive and DMARD-refractory RA-patients is associated with partial reduction of synovial inflammation

ANNALS OF THE RHEUMATIC DISEASES(2004)

引用 0|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要